Pamoja Capital
Pamoja Capital is a private investment firm founded in 2006 by John McCall MacBain and colleagues. Based in Luxembourg, it pursues long-term, socially responsible investments across sectors including education, life sciences and healthcare, information technology, media and communications, real estate and environmental services. The firm engages across growth stages through buyouts, management buyouts and growth equity, seeking opportunities worldwide across Europe, North America, Asia, Oceania and the Middle East. It emphasizes investments with sustainable cash flow and leverages operating experience to support portfolio companies, aiming to deliver enduring value and competitive advantage through a patient, long-term approach.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Kentucky
Talaris Therapeutics
Series B in 2020
Talaris Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies aimed at eliminating chronic immunosuppression for organ transplant recipients. The company's leading product, FCR001, is designed to enable living donor kidney transplant recipients to discontinue all chronic immunosuppression therapy within twelve months post-transplant. In addition to its applications in organ transplantation, Talaris’s technology facilitates the safe use of hematopoietic stem cells from unmatched and unrelated donors for bone marrow transplants, reducing the associated toxicity and risks of traditional methods. Founded in 1988 and originally named Regenerex, Inc., Talaris Therapeutics rebranded in March 2019. The company is headquartered in Louisville, Kentucky, with an additional office in Wellesley, Massachusetts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.